Petlife Pharmaceuticals, Inc. (PTLF) financial statements (2021 and earlier)

Company profile

Business Address 10120 SO. EASTERN AVENUE,
HENDERSON,, NV 89052
State of Incorp. NV
Fiscal Year End August 31
SIC 286 - Industrial Organic Chemicals (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

8/31/2017
8/31/2016
8/31/2015
8/31/2014
8/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments541 7 
Cash and cash equivalents541 7 
Receivables  511 
Inventory, net of allowances, customer advances and progress billings18   
Inventory18    
Prepaid expense1    
Other undisclosed current assets(18)    
Total current assets:551517 
Noncurrent Assets
Intangible assets, net (including goodwill)  1 
Intangible assets, net (excluding goodwill)  1  
Total noncurrent assets:  1  
TOTAL ASSETS:551517 
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:531292235 214
Accounts payable307    
Accrued liabilities224    
Other undisclosed accounts payable and accrued liabilities 292235 214
Debt312    
Derivative instruments and hedges, liabilities102    
Due to related parties101010  
Other undisclosed current liabilities4812,934125 459
Total current liabilities:1,4363,236371 673
Noncurrent Liabilities
Total liabilities:1,4363,236371 673
Stockholders' equity
Stockholders' equity attributable to parent, including:(1,381)(3,235)(365)17704
Preferred stock3    
Common stock74859551
Additional paid in capital28,9303,8883,0211,4754,881
Accumulated other comprehensive income   1,512 
Accumulated deficit(30,388)(7,131)(3,444)(1,512) 
Other undisclosed stockholders' equity attributable to parent   (1,512)(4,178)
Stockholders' equity attributable to noncontrolling interest    (1,378)
Total stockholders' equity:(1,381)(3,235)(365)17(673)
TOTAL LIABILITIES AND EQUITY:551517 

Income statement (P&L) ($ in thousands)

8/31/2017
8/31/2016
8/31/2015
8/31/2014
8/31/2013
Gross profit:  (221)(60)(523)
Operating expenses(1,543)(3,687)(1,932)(1,512)(1,680)
Other undisclosed operating income (loss)(21,113) 22160523
Operating loss:(22,655)(3,687)(1,932)(1,512)(1,680)
Interest and debt expense(595)   58
Loss before gain (loss) on sale of properties:(23,251)(3,687)(1,932)(1,512)(1,622)
Other undisclosed net income    462
Net loss:(23,251)(3,687)(1,932)(1,512)(1,161)
Net income attributable to noncontrolling interest    430
Other undisclosed net loss attributable to parent(6)   (891)
Net loss available to common stockholders, diluted:(23,257)(3,687)(1,932)(1,512)(1,622)

Comprehensive Income ($ in thousands)

8/31/2017
8/31/2016
8/31/2015
8/31/2014
8/31/2013
Net loss:(23,251)(3,687)(1,932)(1,512)(1,161)
Comprehensive loss:(23,251)(3,687)(1,932)(1,512)(1,161)
Comprehensive loss, net of tax, attributable to noncontrolling interest    (430)
Comprehensive loss, net of tax, attributable to parent:(23,251)(3,687)(1,932)(1,512)(1,590)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: